How we prove an L-isoleucine lot is the L form
Identity for L-isoleucine is built from four separate answers, not one: who made the lot and what the record says, which molecule the instrument sees, which configuration the polarimeter reports, and whether the powder meets the physical specification. The assay cannot carry that load alone. A titration at 99% is equally consistent with the L form, the allo epimer, a DL mixture, leucine, norleucine or a powder cut with a diluent.
The titration counts acid groups, the rotation fixes the sign of the configuration, and only a separation that resolves the allo epimer can say how much of it is present.
Four layers of identity
Move from the paperwork to the instrument, then to the geometry, then to the powder. Each layer closes a gap the previous one leaves open.
| Layer | Question it settles | Evidence | Blind spot |
|---|---|---|---|
| Record | What the lot claims to be | Name, CAS 73-32-5, lot code, manufacturer | Says nothing about the drum |
| Substance | Whether the sample is an isoleucine-type amino acid | Infrared, ninhydrin, retention time | Cannot see C-2 or C-3 geometry |
| Configuration | Whether the L form is present and in what proportion | Specific rotation; chiral separation | Small D excess; small allo fraction |
| Form and purity | Whether the powder is the specified grade | Assay, water, residue, pH, mesh | Nothing about configuration |
Read the table from the bottom and the weakness is obvious: the tests that are easiest to run are the ones that say least about which molecule is in the drum.
Rotation and the L configuration
A polarimeter returns an observed angle. Dividing that angle by the path length in decimetres and by the concentration in grams per millilitre gives the specific rotation, which can be compared with the pure material. The catalog window is +38.0° to +41.0° on the dried basis, and the figure is only reproducible when the solvent, concentration, temperature and cell length travel with it: the same lot reads about +40° in 6 M hydrochloric acid and about +12° in water.
The sign is the coarse check. L-isoleucine is positive; D-isoleucine is negative; a racemate falls near zero. An achiral filler such as norleucine also drags the reading toward zero, because it has no optical activity to contribute. A lot outside the window has a real problem.
The allo epimer is where the coarse check runs out. L-alloisoleucine has the same sign and a neighbouring range, so a mixture can land inside +38.0° to +41.0° and still contain several per cent of it. Rotation is a gate on the bulk configuration, not a purity figure for the epimer; the epimer needs a separation.
The solid state, IR, XRD and pH
Infrared spectroscopy identifies the functional groups — carboxylate, ammonium, the branched side chain — and separates an amino acid from a salt, an ester, a blend or a completely different molecule. Ninhydrin confirms the free α-amino group by colour. Both tests pass for L-isoleucine and for L-alloisoleucine, because the functional groups are the same.
X-ray diffraction reads the lattice instead of the groups. The two epimers crystallise into different patterns, so a diffractogram can confirm that a milled or granulated lot is the same solid form as the reference and can flag a mismatch. It is not a quantitative stereochemistry test: a reference pattern can coexist with a small amount of the other epimer.
Solution pH, 5.5–6.5 at 5% concentration, checks the salt form and residual acid or alkali rather than the configuration; the isoelectric point is 6.02. Particle size completes the physical picture: ≥95% through 40 mesh is the standard, and a milled or granulated lot states its mesh in the specification.
The substitution routes
| Route | What the paperwork would show | Test that separates it |
|---|---|---|
| L-alloisoleucine | Same formula, mass and titration; rotation in range | Chiral separation against an allo standard |
| D-isoleucine or a DL mixture | Titration unchanged; rotation low or near zero | Specific rotation; chiral separation |
| Leucine or norleucine | Same formula and mass; leucine rotates much less, norleucine not at all | Validated retention plus rotation |
| Salt or diluted powder | Assay low, residue high, pH moved | Residue on ignition, pH, assay |
The first three routes share the molecular mass, so a mass-spectrometric check that only confirms 131.17 has confirmed very little. Leucine is a constitutional isomer of isoleucine with the same C6H13NO2 formula, and norleucine is another; both have a history of use as nitrogen-rich fillers, and both need a method that resolves them from isoleucine. A retention time is not evidence unless the method has been shown to separate the set.
The crude route is the one the certificate catches. A residue on ignition above 0.1%, a pH outside 5.5–6.5 or an assay under 98.5% points to material other than the free amino acid, before any chiral question is asked.
A specification line that can be enforced
One sentence can fix the molecule, the geometry and the basis: “L-isoleucine, CAS 73-32-5, 98.5–101.5% on the dried basis by titration; specific rotation +38.0° to +41.0° on the dried basis, with the solvent and concentration stated on the certificate; identification by infrared and ninhydrin conforms; loss on drying ≤0.5%; residue on ignition ≤0.1%; pH (5% solution) 5.5–6.5; particle size ≥95% through 40 mesh; heavy metals Pb ≤3, As ≤2, Cd ≤1, Hg ≤0.1 mg/kg; APC ≤1,000 cfu/g, yeast and mould ≤100 cfu/g, E. coli and Salmonella absent.”
Three clauses do the work. The name excludes the epimer and the DL mixture; the dried basis prevents a silent water correction; the solvent beside the rotation makes the value comparable. The catalog does not carry an alloisoleucine limit, so a buyer who needs one adds a clause: alloisoleucine ≤1.0% by a named chiral method, with the limit of quantification written next to it. Agree that number against real lots before it becomes a release limit.
Five questions to put to a supplier
- Does the certificate and the pack name L-isoleucine, and does the specification carry CAS 73-32-5?
- What rotation did this lot give, with which solvent, concentration, temperature and basis?
- Was the lot tested for alloisoleucine, by which method, with what result and what limit of quantification?
- What method and standard produced the assay, and is the result on the dried material? What are the water, residue and pH?
- Can you send the infrared spectrum, the other-amino-acid profile and the metals and micro results for this lot?
Five answers of that kind describe a material rather than a drum. The certificate that should carry them is set out on the COA page; the forms are compared on the grade page and on the L-isoleucine versus L-alloisoleucine page. The product hub carries the catalog specification, the separation is described in the HPLC method note, and assay is defined in the glossary.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation